Human Immunology News Volume 12.07 | Feb 27 2024

    0
    10








    2024-02-27 | HIN 12.07


    Human Immunology News by STEMCELL Technologies
    Vol. 12.07 – 27 February, 2024
    TOP STORY

    An Immunogenetic Basis for Lung Cancer Risk

    Investigators evaluated the effect of human leukocyte antigen heterozygosity on lung cancer risk, leveraging genetic and longitudinal clinical data from the UK Biobank and FinnGen together with multimodal genomic analyses of nonmalignant and lung tumor samples.
    [Science]

    AbstractPress Release
    PUBLICATIONSRanked by the impact factor of the journal

    Identification of a Leucine-Mediated Threshold Effect Governing Macrophage mTOR Signaling and Cardiovascular Risk

    In a series of clinical studies on male and female participants that involved graded amounts of protein ingestion together with detailed plasma amino acid analysis and human monocyte/macrophage experiments, the authors identified leucine as the key activator of mTOR signaling in macrophages.
    [Nature Metabolism]

    AbstractPress Release

    Tumor-Associated Monocytes Reprogram CD8+ T Cells into Central Memory-Like Cells with Potent Antitumor Effects

    Researchers reported that tumor-associated monocytes were highly correlated with the accumulation of CD8+ memory T cells in human cancers.
    [Advanced Science]

    Full Article

    PD-L1-Expressing Tumor-Associated Macrophages Are Immunostimulatory and Associate with Good Clinical Outcome in Human Breast Cancer

    Using single-cell transcriptomic and spatial multiplex immunofluorescence analyses, scientists showed that PD-L1+ tumor-associated macrophages were mature and immunostimulatory with spatial preference to T cells.
    [Cell Reports Medicine]

    Full Article

    Enhancing Chimeric Antigen Receptor T Cell Therapy by Modulating the p53 Signaling Network with Δ133p53α

    Researchers showed that constitutive expression of Δ133p53α potentiated the anti-tumor activity of CD19-directed CAR T cells and limits dysfunction under conditions of high tumor burden and metabolic stress.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    Sex- and Species-Associated Differences in Complement-Mediated Immunity in Humans and Rhesus Macaques

    Investigators analyzed serum samples from 90 humans and 72 rhesus macaques for the abundance and activity of the complement system components.
    [mBio]

    Full Article

    Bulk RNA Sequencing Reveals the Comprehensive Genetic Characteristics of Human Cord Blood-Derived Natural Killer Cells

    Frozen T cell-free cord blood mononuclear cells were cultured with recombinant human interleukin (rhIL)-18 and rhIL-2 in anti-NKp46 and anti-CD16 antibody immobilization settings.
    [Regenerative Therapy]

    Full Article

    Cytokine and Soluble Programmed Death-Ligand 1 Levels in Serum and Plasma of Cancer Patients Treated with Immunotherapy: Preanalytical and Analytical Considerations

    Three Luminex xMAP assays and two ELLA microfluidic cartridges were used to screen 28 immune-related biomarkers in 38 paired serum and citrate-theophylline-adenosine-dipyridamole plasma samples.
    [International Journal Of Biological Markers]

    Full Article

    A Novel Gain-of-Function STAT3 Variant in Infantile-Onset Diabetes Associated with Multiorgan Autoimmunity

    Researchers described a Chinese patient with infantile-onset diabetes and multiorgan autoimmunity. The patient presented with early-onset type 1 diabetes and autoimmune hypothyroidism at seven months.
    [Molecular Genetics & Genomic Medicine]

    Full Article
    Learn how to isolate human monocytes efficiently with EasySepâ„¢ kits
    REVIEWS

    Natural Killer Cell Therapies

    The authors explore in detail the complexity of NK cell biology in humans and highlight the role of these cells in cancer immunity.
    [Nature]

    Abstract

    Emerging Potential of Immunopeptidomics by Mass Spectrometry in Cancer Immunotherapy

    Along with the introduction of key technical advancements in immunopeptidomics, the potential and further directions of immunopeptidomics are reviewed from the perspective of cancer immunotherapy.
    [Cancer Science]

    Full Article
    INDUSTRY AND POLICY NEWS

    ENPICOM Partners with Erasmus University Medical Center in Groundbreaking Effort to Discover Nanobodies against Cancer

    ENPICOM announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.
    [ENPICOM (Life Science Newswire)]

    Press Release
    FEATURED EVENT

    18th World Immune Regulation Meeting

    March 13 – 16, 2024
    Davos, Switzerland

    > See All Events

    JOB OPPORTUNITIES

    Clinical Research – Fellowship Hepatology

    Leeds Teaching Hospital – Leeds, England, United Kingdomn

    Research Associate – Breast Cancer and Brain Tumors

    Cedars Sinai Medical Center – Los Angeles, California, United States

    Research Assistant – Microbial Biochemistry and Pathogenesis

    Queen’s University Belfast – Belfast, Ireland, United Kingdom

    Postdoctoral Researcher – Biology

    Maynooth University – Maynooth, Ireland, United Kingdom

    Postdoctoral Scientist – Liver Cancer Immunology

    Foundation for Liver Research – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2